Skip to main content
Top
Published in: Clinical Rheumatology 7/2016

01-07-2016 | Original Article

Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

Authors: Paolo Sfriso, Roberta Priori, Guido Valesini, Silvia Rossi, Carlo Maurizio Montecucco, Anna D’Ascanio, Linda Carli, Stefano Bombardieri, Gaetana LaSelva, Florenzo Iannone, Giovanni Lapadula, Stefano Alivernini, Gianfranco Ferraccioli, Michele Colaci, Clodoveo Ferri, Daniela Iacono, Gabriele Valentini, Luisa Costa, Raffaele Scarpa, Andrea LoMonaco, Valentina Bagnari, Marcello Govoni, Ilaria Piazza, Silvano Adami, Francesco Ciccia, Giovanni Triolo, Elisa Alessandri, Maurizio Cutolo, Luca Cantarini, Mauro Galeazzi, Piero Ruscitti, Roberto Giacomelli, Francesco Caso, Paola Galozzi, Leonardo Punzi

Published in: Clinical Rheumatology | Issue 7/2016

Login to get access

Abstract

Adult-onset Still’s disease (AOSD) is a systemic inflammatory condition of unknown aetiology characterized by typical episodes of spiking fever, evanescent rash, arthralgia, leukocytosis and hyperferritinemia. Given the lack of data in Italian series, we promote a multicentric data collection to characterize the clinical phenotype of Italian patients with AOSD. Data from 245 subjects diagnosed with AOSD were collected by 15 centres between March and May 2013. The diagnosis was made following Yamaguchi’s criteria. Data regarding clinical manifestations, laboratory features, disease course and treatments were reported and compared with those presented in other published series of different ethnicity. The most frequent features were the following: arthritis (93 %), pyrexia (92.6 %), leukocytosis (89 %), negative ANA (90.4 %) and neutrophilia (82 %). As compared to other North American, North European, Middle Eastern and Far Eastern cohorts, Italian data show differences in clinical and laboratory findings. Regarding the treatments, in 21.9 % of cases, corticosteroids and traditional DMARDs have not been able to control the disease while biologics have been shown to be effective in 48 to 58 patients. This retrospective work summarizes the largest Italian multicentre series of AOSD patients and presents clinical and laboratory features that appear to be influenced by the ethnicity of the affected subjects.
Literature
3.
go back to reference Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590CrossRefPubMedPubMedCentral Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590CrossRefPubMedPubMedCentral
4.
go back to reference Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still’s disease. Int J Clin Pract 63:1050–1055CrossRefPubMed Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still’s disease. Int J Clin Pract 63:1050–1055CrossRefPubMed
5.
go back to reference Fautrel B, Zing E, Golmard J-L et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194–200CrossRef Fautrel B, Zing E, Golmard J-L et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194–200CrossRef
6.
go back to reference Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed
7.
go back to reference Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572CrossRefPubMed Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572CrossRefPubMed
8.
go back to reference Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still’s disease. Autoimmun Rev 13:708–722CrossRefPubMed Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still’s disease. Autoimmun Rev 13:708–722CrossRefPubMed
9.
go back to reference Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still’s disease: a study of 104 cases. Clin Rheumatol 29:1015–1019CrossRefPubMed Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still’s disease: a study of 104 cases. Clin Rheumatol 29:1015–1019CrossRefPubMed
10.
go back to reference Asanuma YF, Mimura T, Tsuboi H et al (2015) Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol 25:393–400CrossRefPubMed Asanuma YF, Mimura T, Tsuboi H et al (2015) Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol 25:393–400CrossRefPubMed
11.
go back to reference Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C (2006) Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 24:123–128PubMed Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C (2006) Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 24:123–128PubMed
12.
go back to reference Priori R, Ceccarelli F, Barone F, Iagnocco A, Valesini G (2008) Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still’s disease. Clin Exp Rheumatol 26:933–937PubMed Priori R, Ceccarelli F, Barone F, Iagnocco A, Valesini G (2008) Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still’s disease. Clin Exp Rheumatol 26:933–937PubMed
13.
go back to reference Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Adult onset Still’s disease: clinical presentation in a large cohort of Italian patients. Clin Exp Rheumatol 28:41–48PubMed Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Adult onset Still’s disease: clinical presentation in a large cohort of Italian patients. Clin Exp Rheumatol 28:41–48PubMed
14.
go back to reference Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M (2011) The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41:279–285CrossRefPubMed Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M (2011) The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41:279–285CrossRefPubMed
15.
go back to reference Dall’Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol. 2016. [Epub ahead of print] Dall’Ara F, Frassi M, Tincani A, Airò P. A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol. 2016. [Epub ahead of print]
16.
go back to reference Zhang Y, Yang Y, Bai Y, Yang D, Xiong Y, Zeng X. Clinical characteristics and follow-up analysis of adult-onset Still’s disease complicated by hemophagocytic lymphohistiocytosis. Clin Rheumatol. 2016. [Epub ahead of print] Zhang Y, Yang Y, Bai Y, Yang D, Xiong Y, Zeng X. Clinical characteristics and follow-up analysis of adult-onset Still’s disease complicated by hemophagocytic lymphohistiocytosis. Clin Rheumatol. 2016. [Epub ahead of print]
17.
go back to reference Cush JJ, Medsger TAJR, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194CrossRefPubMed Cush JJ, Medsger TAJR, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194CrossRefPubMed
18.
go back to reference Kim H-A, Sung J-M, Suh C-H (2012) Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int 32:1291–1298CrossRefPubMed Kim H-A, Sung J-M, Suh C-H (2012) Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int 32:1291–1298CrossRefPubMed
19.
go back to reference Fautrel B, Le Moël G, Saint-Marcoux B et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 28:322–329PubMed Fautrel B, Le Moël G, Saint-Marcoux B et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 28:322–329PubMed
21.
go back to reference Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57CrossRefPubMed Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57CrossRefPubMed
22.
go back to reference Bisagni-Faure A, Job-Deslandre C, Menkes CJ (1992) Intravenous methylprednisolone pulse therapy in Still’s disease. J Rheumatol 19:1487–1488PubMed Bisagni-Faure A, Job-Deslandre C, Menkes CJ (1992) Intravenous methylprednisolone pulse therapy in Still’s disease. J Rheumatol 19:1487–1488PubMed
23.
go back to reference Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26:373–378PubMed Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26:373–378PubMed
24.
go back to reference Dilhuydy MS, Vatan R, Etienne G, Longy-Boursier M, Mercié P (2005) Prolonged efficacy of infliximab for refractory adult-onset Still’s disease. Clin Exp Rheumatol 23:121–122PubMed Dilhuydy MS, Vatan R, Etienne G, Longy-Boursier M, Mercié P (2005) Prolonged efficacy of infliximab for refractory adult-onset Still’s disease. Clin Exp Rheumatol 23:121–122PubMed
25.
go back to reference Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370CrossRefPubMed Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370CrossRefPubMed
26.
go back to reference Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 62:2530–2535CrossRefPubMed Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 62:2530–2535CrossRefPubMed
27.
go back to reference Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis S-NC (2007) Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 66:842–843CrossRefPubMedPubMedCentral Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis S-NC (2007) Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 66:842–843CrossRefPubMedPubMedCentral
28.
go back to reference de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed de Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed
Metadata
Title
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients
Authors
Paolo Sfriso
Roberta Priori
Guido Valesini
Silvia Rossi
Carlo Maurizio Montecucco
Anna D’Ascanio
Linda Carli
Stefano Bombardieri
Gaetana LaSelva
Florenzo Iannone
Giovanni Lapadula
Stefano Alivernini
Gianfranco Ferraccioli
Michele Colaci
Clodoveo Ferri
Daniela Iacono
Gabriele Valentini
Luisa Costa
Raffaele Scarpa
Andrea LoMonaco
Valentina Bagnari
Marcello Govoni
Ilaria Piazza
Silvano Adami
Francesco Ciccia
Giovanni Triolo
Elisa Alessandri
Maurizio Cutolo
Luca Cantarini
Mauro Galeazzi
Piero Ruscitti
Roberto Giacomelli
Francesco Caso
Paola Galozzi
Leonardo Punzi
Publication date
01-07-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3308-8

Other articles of this Issue 7/2016

Clinical Rheumatology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.